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expelled from the host and disease would not occur.
These interactions typically facilitate extracellular colo-
nization or internalization and may initiate a complex
cascade of molecular signaling at the host-pathogen
interface. Recognition and attachment to host tissues
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is mediated by adhesins on the surface of the microbeand Molecular Biophysics
interacting with receptors displayed on the surface ofWashington University School of Medicine
the host cell. In pyelonephritic E. coli, the adhesin PapGSaint Louis, Missouri 63110
binds to a Gal1-4Gal containing glycolipid on the sur-3 Lund University
face of human kidney epithelial cells (Leffler and Svan-Sweden
borg-Eden, 1980; Lund et al., 1987). This interaction
allows the bacteria to gain a foothold on the tissue and
resist being displaced by the mechanical and physicalSummary
forces in the kidney.
The PapG adhesin is assembled into adhesive hair-PapG is the adhesin at the tip of the P pilus that medi-
like fibers called P pili via the chaperone/usher pathwayates attachment of uropathogenic Escherichia coli to
(Sauer et al., 2000; Soto and Hultgren, 1999; Thanassithe uroepithelium of the human kidney. The human
and Hultgren, 2000). This pathway is used by diversespecific allele of PapG binds to globoside (GbO4),
pathogenic gram-negative bacteria for the assembly ofwhich consists of the tetrasaccharide GalNAc1-
over 30 different adhesins that are associated with host3Gal1-4Gal1-4Glc linked to ceramide. Here, we
and tissue tropism (or selectivity) in a wide variety ofpresent the crystal structures of a binary complex of
diseases. P pili are composite fibers consisting of a thinthe PapG receptor binding domain bound to GbO4 as
tip structure called a tip fibrillum that is joined to thewell as the unbound form of the adhesin. The biological
distal end of a thicker structure called the pilus rodimportance of each of the residues involved in binding
(Kuehn et al., 1992). P pilus rods are 68 A˚ in diameterwas investigated by site-directed mutagenesis. These
and are comprised of repeating PapA subunits arrangedstudies provide a molecular snapshot of a host-patho-
in a right-handed helical cylinder consisting of 3.28 sub-gen interaction that determines the tropism of uro-
units per turn (Bullitt and Makowski, 1995). The tip fibril-pathogenic E. coli for the human kidney and is critical
lum of the P pilus is20 A˚ in diameter and is comprisedto the pathogenesis of pyelonephritis.
mostly of repeating PapE subunits arranged in an open
helical configuration. The PapG adhesin is joined to theIntroduction
distal end of the fibrillum via the PapF adaptor and the
fibrillum is joined to the rod by the PapK adaptor (Jacob-
Urinary tract infections (UTI) are one of the most preva-
Dubuisson et al., 1993). All of the pilin subunits share a
lent infectious diseases, second only to infections of the
great deal of homology. The recent crystal structures of
respiratory tract, with 8 million physician visits per year chaperone-subunit complexes revealed that pilin do-
and 1.5 million hospital discharge diagnoses per year mains have incomplete immunoglobulin-like (Ig) folds
(Hooton and Stamm, 1997). One-third of women in the where the seventh strand of a typical Ig fold is missing
United States will have contracted a UTI before the age (Choudhury et al., 1999; Sauer et al., 1999). The periplas-
of 65, and many women experience more than one such mic chaperone, in a mechanism termed donor strand
infection per year. Within six months after an initial UTI, complementation, transiently completes the Ig-like fold
approximately 25% of women will experience a second of each pilin domain by providing the missing secondary
infection and about 3% will suffer a third (Foxman, 1990). structural element. The structure also suggested a
A history of recurrent bladder infections is associated mechanism of pilus assembly, termed donor strand ex-
with an increased risk of developing kidney infections change, in which each subunit contributes its N-terminal
(pyelonephritis), which itself has a recurrence rate of sequence to complete the Ig-like fold of its immediate
about 40% (Patton et al., 1991; Ronald and Pattullo, neighbor in the pilus. The PapG adhesin is comprised
1991). The most frequent causative agent of pyelone- of a C-terminal pilin domain and an N-terminal receptor
phritis is Escherichia coli (Svanborg and Godaly, 1997; binding domain (Hultgren et al., 1989). The pilin domain
Warren, 1996), and the ability of pyelonephritic strains of the adhesin has the characteristic Ig-like fold and
of E. coli to bind (or adhere) to the human kidney has participates in a donor strand exchange reaction with
been shown to be critical in the infection process (Ro- PapF to link PapG to the tip fibrillum. Thus, the mature
berts et al., 1994). pilus consists of an array of over a thousand canonical
Bacterial attachment is a key event in the early stages Ig-like domains, each of which contributes a strand to
of most infectious diseases. Without the ability to specif- the fold of the preceding subunit to produce the organ-
ically adhere to host tissues, pathogens would be readily elle. At the tip of this structure is the N-terminal receptor
binding domain that we have studied here.
Adhesin-receptor interactions, in addition to anchor-4 Correspondence: waksman@biochem.wustl.edu [G.W.]; hultgren@
ing the bacteria to the host tissue, can trigger signalborcim.wustl.edu [S.J.H.]
5 Deceased; this paper is dedicated to his memory. transduction cascades that alter gene expression in
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both bacterial and host cells (Finlay and Falkow, 1997; biguously into electron density (Figure 1A). The structure
of the PapGII receptor binding domain is a mostly Martinez et al., 2000). Binding of host cell receptors
sheet structure that can be subdivided into two regionsby PapG, for instance, activates the transcription of a
(Figure 1B). The first region (region 1), composed ofsensor-regulator protein, AirS, which regulates the bac-
strands b, p, o, c, n, i, and h, forms a  barrel. Theterial iron acquisition system of uropathogenic E. coli
topology of this region is similar to that of the equivalent(Pernestig et al., 2000; Zhang and Normark, 1996). On the
region of the sugar-free form of the receptor bindinghost side, the binding of P pili to Gal1-4Gal-containing
domain of the mannose-specific FimH adhesin (nohost receptors on uroepithelial cells induces the release
bound form for this adhesin has been characterized yetof ceramides, important second messenger molecules
structurally) (Choudhury et al., 1999). The second regionthat can influence a number of signal transduction pro-
(region 2) is composed of a central antiparallel  sheetcesses (Hedlund et al., 1996; Svanborg et al., 1996). In
formed by strands e, a, o, g, k, and j, which is flankedaddition, binding of P-piliated and type 1 piliated bacte-
on one side by two double-stranded  sheets (strandsria result in the up-regulation and eventual secretion
f and l, and d and m, respectively), and, on the otherof several immunoregulatory cytokines from host cells
side, by an  helix (A) and a large loop connecting this(Hedlund et al., 1999; Schilling et al., 2001). Thus, the
helix to strand o. This region contains the receptor bind-interaction between PapG and its glycolipid receptor
ing site and its structure has no equivalent in the da-both initiates bacterial colonization of the kidney and
tabase.modulates the host response.
The glycolipid receptor for PapG consists of a digalac-
The GbO4 Binding Site: Structural Featurestoside (Gal1-4Gal) core linked by a -glucose (Glc)
and Mutagenesisresidue to a ceramide group that anchors the receptor
The receptor binding site of PapGII is located in a pocketin the membrane (Stromberg et al., 1990, 1991). This
formed by strands j, g, and k, helix A, and the loopminimum receptor isotype is called globotriasylcera-
connecting strand o to helix A (Figures 1 and 2). Themide (GbO3). The various members of this receptor fam-
solvent-accessible area of PapGII buried upon bindingily differ by the addition of sugar residues distal to the
of the receptor amounts to 716 A˚2. The tetrasaccharideGal1-4Gal core of GbO3. The addition of a single
binds in a V shape with the reducing end Glc residueN-acetyl-galactosamine (GalNAc) sugar to GbO3 creates
(residue D) and the Gal residue next to it (C) forming oneGbO4 (globoside), whereas the addition of two GalNAc
branch of the V, and the following Gal (B) and GalNAc (A)sugars to GbO3 creates the Forssman antigen (GbO5).
residues forming the other branch.Sialic acids can also be added to form more complex
The Gal1-4Glc (residues C and D) moiety lies overreceptor structures (Stapleton et al., 1998; Stroud et al.,
Trp107 (strand k) and runs parallel to the backbone1998). Three different PapG alleles exist—class I, II, and
structure of strand k between residues 104 and 107.III—which bind with different specificity to different re-
Hydrophobic and aromatic contacts are made between
ceptor isotypes, with class II being the allelle predomi-
Trp107 and the nonpolar face of Gal1-4Glc composed
nantly associated with human pyelonephritis, and class
of the C1, C3, and C5 atoms of residue C and the C4 atom
III being correlated with human cystitis. The differential
of residue D. One polar contact is observed between the
distribution of the receptor isotypes in different hosts N1 of Trp107 and the O3 hydroxyl of residue D. Theseand tissues and the binding specificity of the various interactions are critical in receptor binding: when Trp107
PapG adhesins account for the host and tissue tropisms was changed to an alanine (W107A), receptor binding
of uropathogenic E. coli. was abolished (Figure 3). Interactions of the Gal1-4Glc
In this study, we describe the crystal structures of the moiety with Trp107 occur in the vicinity of a bulge in
apo and GbO4-bound forms of the receptor binding strand k. This bulge is created by the displacement of
domain of the class II PapG adhesin (PapGII). The ad- Lys106 and Asp108 out of a classical alternating strand
hesin-receptor interaction described here is a critical arrangement. Lys106 and Tyr105 are on one side of
event in the ability of pyelonephritic E. coli to cause strand k while Trp107 and Asp108 are on the other.
disease (Roberts et al., 1994). The adhesin-receptor in- A water molecule (W1 in Figure 2A) interacts with the
teractions were further investigated by a structure- backbone nitrogens of Lys106 and Tyr105 and the car-
based site-directed mutagenesis analysis of the binding bonyl oxygens of Gly104 and Tyr60. Further stabilization
pocket. This analysis elucidates how E. coli recognizes of the bulge is achieved by a salt bridge between Asp108
the globoside receptor in the kidney and provides funda- and Arg170. W1 is also involved in receptor binding
mental insights into a key event in bacterial patho- since it is within H bond distance of the O6 hydroxyl of
genesis. residue C. Asp108 is not in direct or water-mediated
contact with the receptor. However, Arg170 (in the loop
between strand o and helix A [the oA loop]) makes inter-
Results and Discussion actions with the O2 and O3 hydroxyls of residue D (Fig-
ure 2). Mutation of Lys106 to alanine (K106A) resulted
Structure of the PapGII Receptor Binding Domain in a slight reduction in hemaglutination titer, suggesting
The structure of the receptor binding domain of PapGII that this side chain plays only a minor role in stabilizing
bound to GbO4 was determined using the multiwave- the binding site (Figure 3). In contrast, an R170A muta-
length anomalous dispersion (MAD) phasing method to tion abolishes binding (Figure 3). This result is consistent
a resolution of 1.8 A˚. The quality of the map was excellent with the observed roles of Arg170 in the structure. Glu59
in strand g interacts directly with the O6 hydroxyl ofand all protein and sugar residues could be built unam-
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Figure 1. Structure of the Binary Complex of the Receptor Binding Domain of the PapGII Adhesin Bound to GbO4 Glycolipid
(A) Experimental solvent-flattened electron density map. The represented region is that of the tetrasaccharide binding site. The final model
of the adhesin domain–tetrasaccharide complex is shown in ball-and-stick representation. The tetrasaccharide is color-coded in blue. Each
sugar residue is labeled, A to D, with A indicating the GalNAc, B and C indicating the Gal1-4Gal galactobiose, and D indicating Glc. The
protein is color-coded by atom types with oxygens in red, nitrogens in blue, and carbons in yellow.
(B) Structure of the PapGII receptor binding domain bound to GbO4. The protein is in ribbon-representation with  strands as cyan arrows,
 helices in red, and loop and coil structures in orange. The tetrasaccharide is in ball-and-stick representation color-coded in magenta. The
Glc, Gal, Gal, and GalNac residues are labeled D to A, respectively. Strands are labeled from a to p, while the  helix is labeled A. Regions
1 and 2 of the structure are indicated by the vertical black arrows and labeled 1 and 2, respectively.
residue C and makes water-mediated contacts with the E91A mutation did not affect PapGII function (Klann et
al., 1994), the E91A and K172A mutations reported hereO2 hydroxyl of residue B. These interactions are shown
to be important by two separate experiments. We dem- reduced or completely abolished receptor binding, re-
spectively (Figure 3), confirming the involvement of bothonstrated that an E59A mutation reduced the ability of
PapG to mediate hemagglutination of human erythro- these residues in receptor binding. Furthermore, deoxy
analogs in the O2, O4, and O6 hydroxyls of residue Bcytes (Figure 3) and previous studies have shown that
deoxy analogs of galabiose, with hydrogen or methyl dramatically reduce PapG-receptor interactions (Kihl-
berg et al., 1989; Striker et al., 1995), further supportinggroups at the O6 position of residue C, have reduced
affinity for the PapG adhesin (Kihlberg et al., 1989; the significance of the interactions described in the pres-
ent study. The C1 and C2 nonpolar region of residue BStriker et al., 1995). No contact is observed between
PapG and the O2 hydroxyl of residue C (Figure 2). This lies on top of a hydrophobic platform comprised of the
aliphatic portion of Lys172, Ile61 (g strand), and Leu102is consistent with previous findings showing that deoxy
analogs of O2 of residue C had no effect on PapG- (strand k).
Finally, residue A of the receptor lies on a platformgalabiose interactions (Kihlberg et al., 1989; Striker et
al., 1995). comprised of Lys172 (in the oA loop) and Glu91. This
platform is extended by two water molecules (W5 andBinding of residue B is mediated in large part by water
molecules (Figure 2). Its O2 hydroxyl is located in the W6 in Figure 2) that also interact with residues Tyr175
in the helix A and Asn92 in strand j. The importance ofproximity of W2 and W3. W2 contacts Glu59 while W3
interacts with Arg170 through W4 (Figure 2A). Another the W5/W6-mediated interaction to Tyr175 is confirmed
by the Y175A mutation which results in a reduction ofwater molecule (W7) on the other side of the binding
site mediates contact between the O6 hydroxyl and the the hemagglutination titer (Figure 3). Lys172 directly in-
teracts with the O5 and the C8 methyl of the N-acetylN group of Lys103 (in strand k). However, this interac-
tion must be weak since a K103A mutation results only group and makes water-mediated contacts (through
W6) with the O4 hydroxyl. Glu91 makes direct H bondin a slight reduction in hemagglutination titer (Figure 3).
Residue B also makes direct contacts with the PapG interactions with the O6 hydroxyl. A few direct intramo-
lecular contacts between receptor residues are ob-binding pocket via H bond interactions between its O4
hydroxyl and the charged tips of Glu91 (in strand j) and served. O3 of residue C contacts O6 and O5 of residue
B, and O2 of residue B contacts O7 of residue A. NoLys172 (in the oA loop). In addition, residue B partici-
pates in hydrogen bonding interactions with the main electron density was observed for the trimethylsilylethyl
(TMSEt) group O-linked to the Glc residue of GbO4.chain nitrogen of Gly104 through its O6 hydroxyl. Al-
though previous studies reported that a double E90A- TMSEt represents a substitute for the ceramide in the
Cell
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Figure 2. The GbO4 Binding Site
(A) Stereo-diagram of binding site. The protein backbone is in ribbon representation as in Figure 1B and secondary structures are labeled
according to Figure 1B. Residues in the protein interacting with the GbO4 receptor are in ball-and-stick representation with carbon atoms in
gray, oxygen atoms in red, and nitrogen atoms in blue. Receptor residues are in ball-and-stick representation with carbon atoms in silver,
and oxygen and nitrogen atoms as in the protein. Water molecules involved in interactions between the protein and receptor residues are in
ball representation color-coded in magenta and labeled W1 to 7. Receptor residues are labeled A to D as in Figure 1B.
(B) Schematic representation of interactions between protein and receptor. Direct polar interactions are indicated by red arrows. Water-
mediated interactions are indicated by blue arrows. Brackets and arrows in green indicate contacts with aromatic/hydrophobic platforms.
glycolipid. Hence, the ceramide group is likely not in- bound form compared to the bound form (see Experi-
mental Procedures). Nevertheless, the crystals be-volved in binding in vivo.
longed to the same space group and the unit cell
dimensions were very similar. The structure of the un-Apo PapG
In order to investigate whether the interaction between bound form of the protein is strikingly similar to that of
the complex form (root-mean-square deviation of 0.16 A˚PapG and its globoside receptor requires conforma-
tional changes in PapG or a rearrangement of the water in backbone atom positions; Figure 4). Hence, the inter-
actions between the protein and its receptor appear tomolecules around the binding site, the unbound form of
the PapGII receptor binding domain was crystallized. be of a rigid body type which does not involve conforma-
tional changes in the protein. Residues involved in GbO4Crystallization conditions were very different for the un-
Crystal Structure of an Adhesin-Receptor Complex
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apo form, only five waters were visible in the binding
site, and only one of those (W2) was found bound in the
same location (Figure 4). The four other water molecules
were found in positions equivalent to where atoms in
the GbO4 receptor were located when bound to PapG.
Three of the water molecules were most closely aligned
with three of the Gal1-4Gal core hydroxyls known to
be important in receptor binding: the O6 of the residue
C, and the O4 and O6 of the residue B. In the bound form,
these hydroxyls make contacts with the side chains of
residues 59 and 91 and with the main chain nitrogen of
residue 104. Thus, binding of PapG to its receptor must
involve displacement of these water molecules.
Figure 3. Mutational Studies of the GbO4 Binding Site Model for Pilus-Uroepithelium Interaction
The hemagglutination relative to wild-type PapGII is indicated in the From the crystal structure of the PapGII-GbO4 complex,
bar graph for each of the mutants. Expression and display of the
a model can be derived as to how the tip of the P pilusadhesin mutants in the tip fibrillum of purified P pili is shown on
approximates its receptor on the cell surface of thethe gel underneath the bar graph.
kidney (Figure 5). One intriguing feature of the receptor
binding site of the PapG adhesin is its location on the
side of the molecule. The PapG adhesin consists ofbinding undergo only slight changes in side chain con-
formation or backbone structure (Figure 4). The primary two domains, one (N-terminal) is the receptor binding
domain and the other (C-terminal) termed “pilin” domaindifference between the apo and bound forms of PapG
is the structure of water molecules in and around the has an Ig-like fold structure and is connected to the
tip fibrillum via donor-strand exchange with the PapFreceptor binding site. There exist seven water molecules
mediating interactions between the receptor and the adaptor. The pilin and receptor binding domains of PapG
are arranged head-to-tail with a short 3 amino acid linkerprotein in the bound complex (described above). In the
Figure 4. The Structure of the Unbound Form
of the PapGII Receptor Binding Domain
(A) Superimposition of the structures of the
apo (in lavender) and bound (in cyan) forms
of the PapGII receptor binding domain. The
two forms are in stereo-ribbon representa-
tion; the N- and C-terminal ends of the protein
are indicated.
(B) Superimposition of the GbO4 binding site
in the apo (in lavender) and bound (in cyan)
forms. Side chains of residues involved in
GbO4 binding are indicated in ball-and-stick
representation. The 7 waters mediating pro-
tein-receptor interactions in the bound state
are shown with cyan balls. The 5 waters
bound in the GbO4-free state of the protein
are indicated with lavender balls. The recep-
tor-bound water, W2, is indicated.
Cell
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Figure 5. Model of the Interactions of the
PapGII Adhesin at the Membrane
(A) A P pilus. The PapG adhesin is located at
the thin tip of the pilus. Note the bend at
the tip of the pilus, which places the PapG
adhesin in a proper orientation for side-on
binding to the membrane.
(B) Model of PapGII receptor binding domain
interacting with GbO4-ceramide. This model
was generated by attaching a ceramide
group to the Gal1-4Glc moiety of GbO4 such
that the resulting Gal1-4Glc-ceramide
would adopt a configuration similar to that
crystallographically observed for a digalacto-
side-ceramide (Pascher et al., 1992). The mo-
lecular surface is that of the protein, color-
coded according to charge, blue for positive
(Arg and Lys) and red for negative (Glu and
Asp). Charged residues which could poten-
tially interact with the head groups of the
eukaryotic membrane are labeled. The GbO4-
ceramide is in CPK representation with car-
bon atoms in green, oxygen atoms in red, and
nitrogen atoms in blue.
(C) Model of uroepithelium. The GbO4-cera-
mide is represented as in (B) and is labeled
“GbO4”.
between the two domains. Such a configuration thus shown that PapGII, but not PapGI, specifically recog-
nized the reducing Glc residue (Kihlberg et al., 1989;places the receptor binding surfaces which we have
characterized here on the side of the pilus tip. Interest- Striker et al., 1995).
The structural basis of this binding specificity is sug-ingly, the structure of a modeled galactosylceramide
indicates that the globoside moiety of the receptor ap- gested by the structure presented here. The amino acid
sequence of PapGI (Figure 6A) was threaded onto theproaches a perpendicular angle in relation to the cera-
mide group (Pascher et al., 1992). Thus, in order for PapGII structure and amino acid differences on the
PapGII surface were identified (Figure 6B, top panel). Thethe PapG’s receptor binding pocket to interact with the
GbO4 glycolipid, the receptor binding domain must be region involved in contacting residue D (Glc) was found
to be comprised of amino acid residues that vary be-oriented with its N- to C-terminal axis approaching a
parallel orientation to the membrane so that it can dock tween PapGI and PapGII. The most notable substitution
is Arg (in PapGII) to His (in PapGI) at position 170 (Figureto the receptor. This orientation may be facilitated by
the flexibility inherent in the tip fibrillum of the P pilus 6A). Arg170 makes interactions with Glc. These interac-
tions would presumably not occur when a His occupiesas evidenced by high-resolution EM (Figure 5). In fact,
a flexible tip fibrillum may be required to present the this position, thus explaining the lack of interactions
between PapGI and the Glc at the reducing end of globo-receptor binding surface “side-on” to the membrane-
bound receptor. The side-on orientation appears also side (Striker et al., 1995). The regions of PapGII inter-
acting with the galabiose core (residues B and C) andto be faciliated by the preponderance of charged resi-
dues on the surface adjacent to the binding site that GalNAc (residue A) of GbO4 are well conserved between
PapGI and PapGII (Figure 6B). This explains why thesemay facilitate docking to the polar head groups of the
eukaryotic lipid membrane (Figure 5). adhesins cannot discriminate between GbO3 and GbO4
in vitro as both would presumably make the same inter-
actions with the galabiose core. However, in vivo, PapGIIBinding Specificity of the PapG Adhesins
The P pilus architecture serves as a platform to present exhibits a distinct preference for membrane-inserted
GbO4 over GbO3 (Stromberg et al., 1991). This bindingthree known classes of adhesin variants: PapGI, PapGII,
and PapGIII (Stromberg et al., 1990). The binding proper- behavior was investigated by Stromberg et al. (1991),
who showed that GbO3 and GbO4 are likely to adoptties of the PapG adhesins differ depending on whether
binding is assessed with glycolipid substrates inserted different conformations when inserted in the membrane.
The Glc residue in membrane-anchored GbO3 was pre-in natural membranes or immobilized on artificial
surfaces (Stromberg et al., 1990, 1991). PapGI, II, and dicted to be partially buried in the membrane, while
the same residue in membrane-anchored GbO4 wasIII adhesins preferentially bind to membrane-inserted
GbO3, GbO4, and GbO5, respectively (Stromberg et al., predicted to be more exposed due to the effect of the
GalNac residue on the spatial orientation of the tetrasac-1990). On artificial surfaces, PapGIII still clearly exhibits
specificity toward GbO5; however, PapGI or PapGII ap- charide with respect to the membrane surface (Strom-
berg et al., 1991). Since Glc is required for optimal PapGIIpear to bind equally well to GbO3 and GbO4 (Stromberg
et al., 1991). Recent studies have further elucidated the binding, the masking of Glc in membrane-inserted GbO3
would negatively affect PapGII binding to this glycolipidspecificities that differentiate receptor recognition be-
tween the PapGII and PapGI adhesins (Striker et al., (Striker et al., 1995).
Differences between the receptor binding sites of1995). Using a large set of receptor analogs, it was
Crystal Structure of an Adhesin-Receptor Complex
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Figure 6. Conservation of Residues among PapG Adhesins and Model of the PapGIII Adhesin
(A) Sequence alignment of the PapGI, PapGII, and PapGIII sequences. The secondary structural elements are indicated below the aligned
sequences, with  strands and  helices in light blue and red boxes, respectively. Strictly conserved residues between the three adhesin
classes are in purple boxes. Residues involved in receptor binding in PapGII are indicated in green.
(B) Surface mapping of conserved (purple), similar (gold), and nonconserved (white) residues between the PapGII and PapGI adhesins (top
panel) and the PapGII and PapGIII adhesins (bottom panel). The surface of the represented binding site is that of PapGII. The receptor is in
stick representation color-coded as in Figure 4B. Similarity (gold) between residues is defined by the following groups (E:D), (R:K), (A:L:V:I:M),
(F:Y:W), (N:Q), and (S:T:C) where residues within parentheses are defined as similar. Residues strictly conserved among the three adhesins
are in deep purple while residues only conserved among the two adhesins compared in either the top or bottom panel are in light purple.
(C) Theoretical model of the PapGIII receptor binding site bound to GbO5 (sequence GalNAc1-3GalNAc1-3Gal1-4Gal1-4Glc). The receptor
(GbO5) is in stick representation color-coded as in Figure 5B and labeled as in Figure 1. The nonreducing end GalNAc is labeled GalNAc.
The solvent-accessible surface of the modeled PapGIII binding site is represented and color-coded according to surface electrostatic potential
(calculated using DELPHI [Nicholls and Honig, 1991] and displayed [blue for positive and red for negative] using INSIGHTII [MSI, San Diego]).
PapGIII’s residues in contact with GbO5 are labeled. The sequence of PapGIII was threaded onto the PapGII structure using the program
SwissModel (Guex et al., 1999) and optimized using the program Discover (MSI, San Diego). A model of GbO5 was initially obtained by adding
a GalNAc residue to the O3 of the GalNAc residue of GbO4. The resulting GbO5 was then docked onto the PapGIII structure using a Monte-
Carlo-based algorithm implemented by the program Discover. The GbO5/PapGIII complex with lowest energy was minimized using conjugate
gradient method (program Discover).
Cell
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Table 1. Data Collection and Refinement Statistics
Data collection*
Completeness (%)*
Data set Resolution Reflections (Total/Unique) (I/I  0) Rsym (%)#,* I/(I)*
SeMet-inflection 30–1.8 A˚ 395,851 / 32,839 93.7 (74.8) 4.7 (28.5) 17.1 (1.4)
Se-Met peak 30–1.8 A˚ 395,514 / 32,770 94.4 (80.9) 4.6 (27.9) 18.4 (1.6)
Se-Met remote 30–1.8 A˚ 395,870 / 32,819 94.1 (79.2) 4.3 (30.5) 17.7 (1.4)
Apo form 30–2.1 A˚ 155,672 / 20,308 93.5 (82.4) 5.6 (23.2) 24.1 (4.3)
Refinement
Bound Unbound
Resolution 30–1.8 A˚ 30–2.1 A˚
|F|/|F| 1 1
Number of reflections (working / test) 28,277 / 1,489 17,220 / 1,867
Completeness (overall/last shell)* 91.0 (75.8) 93.3 (81.8)
Total number of atoms 1,838 1,716
Protein atoms 1,605 (196 residues) 1,605
GbO4 48 (1 tetrasaccharide)
Water molecules 185 111
R factor 0.22 0.23
R free factor 0.24 0.25
Averaged B factors (A2)
Main chain 30.2 30.1
Side chain 31.0 30.9
Rms deviations
Bonds (A˚) 0.010 0.006
Angles () 1.587 1.317
B values (A˚2) 0.8 / 1.8 0.8 / 1.7
* Numbers in parentheses indicate values in the highest resolution shell (1.86–1.80 A˚ for bound state data and 2.18–2.1 A˚ for apo state data).
# Rsym  	|I 
 I|/	I, where I  observed intensity, and I  average intensity for symmetry-related reflections.
PapGII and PapGIII mostly lie in the region where the Conclusion
second GalNAc residue of GbO5 (the PapGIII sub-
strate) would locate (see the Glu90, Tyr175, and Asn92 The ability of pathogens to recognize host receptors is
a critical event in most infectious diseases. The recogni-region in Figure 6B, bottom panel). Hence, the difference
in selectivity between PapGII and PapGIII may be ex- tion event is often mediated by a bacterial adhesin lo-
cated at the tip of a pilus structure. The P pilus is oneplained by the fact that substitutions to PapGIII residues
in that region may result in the formation of an additional of the most extensively studied adhesive fibers pro-
duced by bacteria and has served as a prototype forGalNAc binding subsite capable of accommodating the
second nonreducing end GalNAc of GbO5. To explore understanding host pathogen interactions for over a de-
cade (Sauer et al., 2000; Soto and Hultgren, 1999; Tha-this possibility, a model of PapGIII bound to GbO5 was
generated (Figure 6C). In PapGIII, Glu91 is substituted nassi and Hultgren, 2000). A vast amount of work has
been carried out in an attempt to characterize the molec-to Asp. This allows space for a groove in which the
GalNAc1-3GalNAc moiety of GbO5 could lie. This ular basis of the tropism that the PapG adhesin de-
termines and the function of the PapG-globoside in-groove is completed on the Lys172 side (i.e., the oA
loop side) by Pro174 and Ser175 (substituting to Tyr175 teraction in disease. The three-dimensional structure
presented here provides a view of these interactions,in PapGII) and on the other side by residues in strand j
and in the jk loop (Asp91 and Glu93). Glu93 in PapGIII thereby revealing the molecular basis of a critical event
in pyelonephritis: the colonization of the kidney. Theis predicted to project toward the GalNAc of GbO5 and
make H bond interactions with its O3 and O4 hydroxyls structure of the adhesin-receptor complex reveals an
intricate network of interactions between the adhesinas well as with the N2 of its N-acetyl group. GbO4 is
the dominating galabiose-containing isoreceptor in the and the glycolipid receptor that is likely to reflect a gen-
eral mechanism for the function of all bacterial adhesins.human kidney in contrast to the canine kidney where
GbO5 predominates. PapGII and PapGIII favor coloniza- The mutational analysis presented here, in concert with
earlier studies using specific receptor analogs, pinpointtion of the human and dog kidney, respectively (Strom-
berg et al., 1990). Thus, the structure presented here the importance of the interactions required for a stable
adhesin-receptor interaction. In addition, the structurenot only reveals the molecular basis for the tropism
conferred by the PapGII adhesin but also suggests a predicts that the adhesin domain binds “side-on” to the
eukaryotic membrane, which suggests a requirementplausible model that accounts for the tropism conferred
by PapGIII. This model also predicts that GbO5-con- for a tip fibrillum flexible enough to orientate the receptor
binding surfaces parallel to the membrane. Understand-taining receptors may predominate in the adult human
bladder over GbO3 or GbO4, since PapGIII containing ing the fine molecular details of host pathogen interac-
tions will lead to the development of adhesin-basedstrains are more prevalent in human cystitis than PapGII
containing strains (Johnson et al., 1998). vaccines that are rationally designed to inhibit the patho-
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ware factory (http://xray.bmc.uu.se/usf). The free R factor was moni-genic process at an early stage and will provide a frame-
tored as an indicator of model improvement (Bru¨nger, 1992). Waterwork that will be used in the rational design of novel
molecules were added conservatively. After bulk solvent and overallantibiotic compounds. Thus, continued research into
anisotropic B-factor correction, the refinement converged to a final
the structure, function, and biogenesis of bacterial ad- R factor of 21.9% with an R free factor of 24.0% (30–1.8 A˚ resolution
hesins promises not only to enhance our knowledge of data; |F|/|F|  1.0) with good stereochemistry (Table 1). The model
includes residues 1–196, 1 molecule of GalNAc1-3Gal1-4Gal1-pathogenic processes, but may also help augment our
4Glc, and 185 water molecules. All phi and psi angles lie in thecurrent arsenal of antimicrobial agents.
allowed region of the Ramachandran plot with 95% in the most
favored regions.Experimental Procedures
For the unbound form, crystals diffracted to a resolution of 2.1 A˚
in the laboratory setting (Rigaku Raxis IV image plate mounted onCloning, Protein Expression, and Purification
a Rigaku RU200 rotating anode X-ray generator). The atomic modelStandard PCR and recombinant techniques were used to amplify
corresponding to the protein part of the refined complex structureand subclone the signal sequence and the N-terminal 196 amino
was used directly in refinement against the unbound form dataacids of PapG class II which contain the receptor binding domain
(Table 1) using simulated annealing (Bru¨nger et al., 1987). Waterof PapGII to create the plasmid pTRCGII196. C600/pTRCGII196 was
molecules were then added in electron density. After bulk solventthen grown and expression of GII196 was induced by addition of
and overall anisotropic B-factor correction, R and free R factorIPTG to 0.1 mM. Cells were harvested and processed for periplasmic
values are 23.2% and 25.4% (30–2.1 A˚ resolution data; |F|/|F| extracts by resuspension in 20 mM Tris HCl (pH 8.0), 20% sucrose,
1.0) with good stereochemistry (Table 1).5 mM EDTA, and 150 g/ml lysozyme. MgCl2 was added to 10 mM,
followed by centrifugation at 12 K for 40 min. The PapGII receptor
Mutational Studies and Hemaglutination Assaybinding domain was selectively precipitated using 30% ammonium
Mutations in residues involved in receptor binding were made insulfate. After centrifugation, the pellet was resuspended and dia-
the full-length papGII gene from pDC1 (Clegg, 1982) by standardlyzed in 20 mM MES (pH 5.8). The GII196 protein was then purified
PCR methods and verified by sequence analysis. The ability of theusing S Sepharose and butyl hydrophobic interaction chromotagra-
mutated PapGII adhesins to be localized to the tip of P pili wasphy. The pure protein was dialyzed against 20 mM MES (pH 5.8). To
verified by labeling for 1 hr C600 cells containing pKD320 (papCD-produce the selenomethionine-substituted (SeMet-GII196) protein,
KEFG::kan) and the pTRCpapGII variants with 35[S]methionine andpTRCGII196 was transferred in DL41 and grown in LeMaster medium
cysteine (100 Ci/ml) after growth in minimal M9/PO4 medium tocomplemented by selenomethionine (Lemaster and Richards, 1985).
an OD600 of0.6 and inducing with 1 mM IPTG. Cells expressing PapProduction and purification of SeMet-GII196 were as for wild-type.
tips were pelleted and resuspended in phosphate-buffered saline,
heated to 65C for 30 min to release Pap tips, and pelleted. The Pap
Crystallization and Structure Determination tip-containing supernatants were then immunoprecipitated using
GII196 (the receptor binding domain of PapGII) was concentrated protein G Sepharose beads and anti-tip antibody. The beads were
to 4–5 mg/ml. The binary complex was formed by adding a 2 molar then pelleted, washed twice with RIPA Buffer (100 mM Na2HPO4 [pHexcess of an analog of GbO4 containing a O-linked trimethylsily- 8.0], 150 mM NaCl), and twice with RIPA buffer  1 M NaCl, and
lethyl (TMSEt) group instead of ceramide. Hence, the chemical com- finally once again with RIPA buffer. SDS-PAGE and autoradiography
position of the GbO4 coumpound used in this study is: GalNAc1- of the immunoprecipitated samples confirmed that each of the mu-
3Gal1-4Gal1-4GlcOTMSEt. Crystals of the binary complex were tated adhesins was able to be localized to Pap tips. Hemaglutin-
obtained by the hanging drop vapor diffusion method using a reser- ations, a measure of the ability of the PapGII being expressed at
voir solution containing 100 mM sodium citrate (pH 5.2), and 0.5 M the distal end of P pili to bind to GbO4 present on red blood cells,
to 1.1 M ammonium acetate. Crystals of the unbound form were were carried out using the strain HB101/pFJ29G::kan transformed
grown by vapor diffusion against a reservoir containing 4% (w/v) with a pTRC99 vector encoding the wild-type or the indicated papGII
PEG20,000. Apo and complex crystals were cryoprotected by the mutants and human erythrocytes as described previously (Hultgren
sequential addition of glycerol to a final concentration of 30%. Both et al., 1990). In brief, the bacteria expressing P pili containing the
apo and complex crystals were in space group I222 with unit cell PapG variants were resuspended in phosphate buffered saline (PBS)
dimensions a  55.1 A˚, b  79.7 A˚, and c  158.0 A˚ for the complex to an OD600 1.0 and then pelleted and resuspended in 1/10 volumecrystals and a  55.1 A˚, b  78.2 A˚, and c  158.4 A˚ for the of PBS. These bacterial suspensions were serially diluted in 2-fold
apo form crystals. Both apo and complex crystals contained one increments in v-bottom microtiter plates. PBS-washed human eryth-
complex per asymmetric unit. SeMet-GII196 crystallized under simi- rocytes (OD640 1.7) were added to each well and the plates incu-lar conditions and the complex SeMet-containing crystals were iso- bated at 4C for 2–16 hr. The ability of the various bacterial dilutions
morphous to those grown from the wild-type protein. to prevent erythryocytes from settling over a given incubation period
SeMet-GII196 contains three selenomethionines. MAD data were is a measure of the ability of the adhesin to bind to GbO4 present
collected to a resolution of 1.8 A˚ at three wavelengths using a on the erythrocytes.
single complex crystal (beamline 19BM, Structural Biology Center,
Advanced Photon Source). Data were indexed, integrated, and re-
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